FinTech
Respiri: Extends US partnership with Access Telehealth
Respiri Extends US partnership with Access TelehealthRespiri (RSH) signs a second, five-year, non-exclusive distribution and marketing agreement with Access Telehealth in the United...
FinTech
Respiri: Receives FDA tick for Wheezo
Respiri (RSH) has received United States Food and Drug Administration (FDA) clearance for its wheezing aid, Wheezo
Wheezo monitors wheezing to manage and...
Business
Respiri: Completes share purchase plan to raise $3.14M
Respiri: Completes share purchase plan to raise $3.14MeHealth software provider Respiri (RSH) has completed a share purchase plan (SPP) to raise $3.14M
Originally,...
Banking
Respiri: Raises $2M to develop wheezo respiratory device
Respiri: Raises $2M to develop wheezo respiratory deviceHealth technology company Respiri (RSH) has raised $2M through a share placement
Then the money raised...
FinTech
Respiri: Receives first batch of wheezos
Respiri: Receives first batch of wheezosHealth technology company Respiri (RSH) has received its first batch of wheezos, to help with wheeze detection
Wheezo...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read